Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
RSC Advances|May 29, 2024
Advances in chromone-based copper(ii) Schiff base complexes: synthesis, characterization, and versatile applications in pharmacology and biomimetic catalysisSumit Kumar, Aditi Arora, Vipin K Maikhuri, et al.
In Silico Pharmacology|December 23, 2025
Integrated cytotoxicity screening and in silico analysis of coumarin nucleoside conjugates as computationally modeled VEGFR-2 inhibitors: oncocyte cytotoxicity, molecular docking, and dynamics simulation studiesDivya Mathur, Vipin K Maikhuri, Sushma Yadav, et al.
Cureus|December 7, 2023
Improving Discharge Rates to Home With the Help of Mobility Technicians: A Step in the Right DirectionSwapnil V Patel, Steven Imburgio, Anmol S Johal, et al.
Pharmaceutical Biology|May 29, 2015
Structure-activity relationship studies of 4-methylcoumarin derivatives as anticancer agentsRamin Miri, Maryam Nejati, Luciano Saso, et al.
Physical Therapy|December 19, 2018
Physical Therapist Student Readiness for Entrance Into the First Full-Time Clinical Experience: A Delphi StudyJean F Timmerberg, Robin Dole, Nicki Silberman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|May 6, 2016
Synthesis and anti-inflammatory activity evaluation of novel triazolyl-isatin hybridsPramod K Sharma, Sakshi Balwani, Divya Mathur, et al.
Molecules (Basel, Switzerland)|November 12, 2016
Biocatalytic Synthesis of Novel Partial Esters of a Bioactive Dihydroxy 4-Methylcoumarin by Rhizopus oryzae Lipase (ROL)Vinod Kumar, Divya Mathur, Smriti Srivastava, et al.
Cureus|June 6, 2024
Improving Patient Outcomes Using Measures to Increase Discharge Rates to HomeSwapnil V Patel, Anne Arcidiacono, Christopher P Austin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2009
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4Costas A Lyssiotis, Ruth K Foreman, Judith Staerk, et al.
Molecular Imaging and Biology|June 18, 2021
Preclinical Evaluation of <sup>89</sup>Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging TherapyKevin P Maresca, Jianqing Chen, Divya Mathur, et al.
Pageof 4